Krystyna Dabrowska
Krystyna Dabrowska
Hirszfeld Institute of Immunology and Experimental Therapy
Verified email at hirszfeld.pl - Homepage
Title
Cited by
Cited by
Year
Bacteriophage penetration in vertebrates
K Dabrowska, K Switała‐Jelen, A Opolski, B Weber‐Dabrowska, A Gorski
Journal of applied microbiology 98 (1), 7-13, 2005
2822005
Bacteriophage translocation
A Górski, E Ważna, BW D±browska, K D±browska, K ¦witała-Jeleń, ...
FEMS Immunology & Medical Microbiology 46 (3), 313-319, 2006
2202006
Phage as a modulator of immune responses: practical implications for phage therapy
A Górski, R Międzybrodzki, J Borysowski, K D±browska, P Wierzbicki, ...
Advances in virus research 83, 41-71, 2012
1982012
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
K Hodyra-Stefaniak, P Miernikiewicz, J Drapała, M Drab, ...
Scientific reports 5, 14802, 2015
1612015
Interactions between bacteriophage, bacteria, and the mammalian immune system
J Van Belleghem, K D±browska, M Vaneechoutte, J Barr, P Bollyky
Viruses 11 (1), 10, 2019
1502019
Biotechnological applications of bacteriophages: state of the art
LK Harada, EC Silva, WF Campos, FS Del Fiol, M Vila, K D±browska, ...
Microbiological research 212, 38-58, 2018
1162018
Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases
A Górski, R Międzybrodzki, B Weber-D±browska, W Fortuna, S Letkiewicz, ...
Frontiers in microbiology 7, 1515, 2016
1142016
Immunogenicity studies of proteins forming the T4 phage head surface
K D±browska, P Miernikiewicz, A Piotrowicz, K Hodyra, B Owczarek, ...
Journal of virology 88 (21), 12551-12557, 2014
1092014
Phages and immunomodulation
A Górski, K D±browska, R Międzybrodzki, B Weber-D±browska, ...
Future microbiology 12 (10), 905-914, 2017
1022017
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
K D±browska
Medicinal research reviews, 2019
1012019
Oral application of T4 phage induces weak antibody production in the gut and in the blood
J Majewska, W Beta, D Lecion, K Hodyra-Stefaniak, A Kłopot, ...
Viruses 7 (8), 4783-4799, 2015
1012015
New insights into the possible role of bacteriophages in host defense and disease
A Gorski, K Dabrowska, K Switala-Jeleń, M Nowaczyk, ...
Medical Immunology 2 (1), 2, 2003
962003
Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool
Z KaĽmierczak, A Górski, K D±browska
Viruses 6 (7), 2551-2570, 2014
932014
Effects of bacteriophages on free radical production and phagocytic functions
A Przerwa, M Zimecki, K ¦witała-Jeleń, K D±browska, E Krawczyk, ...
Medical microbiology and immunology 195 (3), 143-150, 2006
932006
Bacteriophages and transplantation tolerance
A Górski, M Kniotek, A Perkowska-Ptasińska, A Mróz, A Przerwa, ...
Transplantation proceedings 38 (1), 331-333, 2006
852006
Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes
R Miedzybrodzki, K Switala-Jelen, W Fortuna, B Weber-Dabrowska, ...
Virus research 131 (2), 233-242, 2008
782008
Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway.
K Dabrowska, A Opolski, J Wietrzyk, K Switala-Jelen, J Boratynski, ...
Acta virologica 48 (4), 241-248, 2004
742004
Phage therapy: what have we learned?
A Górski, R Międzybrodzki, M Łobocka, A Głowacka-Rutkowska, ...
Viruses 10 (6), 288, 2018
732018
The biological functions of beta3 integrins.
K Switala-Jelen, K Dabrowska, A Opolski, L Lipinska, M Nowaczyk, ...
Folia biologica 50 (5), 143-152, 2004
692004
T4 phage and its head surface proteins do not stimulate inflammatory mediator production
P Miernikiewicz, K D±browska, A Piotrowicz, B Owczarek, J Wojas-Turek, ...
PLoS One 8 (8), e71036, 2013
672013
The system can't perform the operation now. Try again later.
Articles 1–20